awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30249836-1AF3DE30-8B18-4B58-8DF5-CD6D3100C9A6
Q30249836-1AF3DE30-8B18-4B58-8DF5-CD6D3100C9A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30249836-1AF3DE30-8B18-4B58-8DF5-CD6D3100C9A6
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.
P2860
Q30249836-1AF3DE30-8B18-4B58-8DF5-CD6D3100C9A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30249836-1AF3DE30-8B18-4B58-8DF5-CD6D3100C9A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e8a7adfcaff5bde9a4696b32a4da9f6a461d1d8
P2860
Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis.